Cinclus Pharma (CINPHA) — Financial Flexibility Index
Cinclus Pharma (CINPHA) has a Financial Flexibility Index of -0.39x as of June 2026. Free cash flow of Skr-86.19 Million (operating CF Skr-86.19 Million minus capex Skr0.00) represents 0% of total liabilities (Skr221.84 Million). Check CINPHA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cinclus Pharma Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Cinclus Pharma across 4 annual periods. For the full cash flow conversion analysis, see CINPHA cash flow metrics.
Annual Financial Flexibility Index for Cinclus Pharma (2022–2025)
Year-by-year free cash flow to debt coverage for Cinclus Pharma. Explore how well can Cinclus Pharma service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.41x | Skr-73.51 Million | Skr-74.65 Million | Skr177.16 Million | ▲ +89.4% |
| 2024 | -3.90x | Skr-178.37 Million | Skr-178.37 Million | Skr45.68 Million | ▼ -219.6% |
| 2023 | -1.22x | Skr-209.19 Million | Skr-209.19 Million | Skr171.21 Million | ▲ +62.5% |
| 2022 | -3.26x | Skr-192.08 Million | Skr-192.08 Million | Skr58.90 Million | — |